Ewha Womans University Medical Center
| République de Corée | Turquie | Espagne | |
| Traitement symptomatique | - | de $300 | de $800 |
Bookimed ne rajoute pas de frais pour les traitements de Polykystose rénale. Les tarifs proviennent des listes de prix officielles des cliniques. Vous payez directement à la clinique pour votre traitement à votre arrivée dans le pays.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans le traitement de Polykystose rénale et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de traitement de Polykystose rénale.
Présenté à deux reprises dans l'émission « Medical Experts » d'EBS pour les troubles de la prostate et les calculs urinaires, le Dr Lee apporte une expertise urologique de haut niveau aux cas de polykystose rénale.
Tolvaptan is available in South Korea for treating Autosomal Dominant Polycystic Kidney Disease (ADPKD). The Ministry of Food and Drug Safety approved it in 2015. National Health Insurance has covered this medication since 2019 for specific adult patients with rapid disease progression.
Bookimed Expert Insight: South Korea is a leader in medical digitalization. Centers like Seoul National University Bundang Hospital use the BESTcare system to track drug titration. This digital monitoring is vital for Tolvaptan. It ensures precise dosing and safety for patients with fluctuating renal function.
Patient Consensus: While international discussions often focus on high costs, patients in Korea benefit from national insurance coverage. Many emphasize the need for strict adherence to the monthly blood test schedule required by local regulations.
Asan Medical Center, Seoul National University Hospital, and Severance Hospital are the premier facilities for polycystic kidney disease and transplants. These JCI-accredited institutions report transplant success rates up to 98%. They utilize advanced robotic systems and multidisciplinary teams for complex inherited conditions.
Bookimed Expert Insight: Patient volume is a primary indicator of quality in Seoul. Asan Medical Center treats 11,800 outpatients daily and manages 45% of Korea's heart transplants. This high volume across all organ categories ensures surgeons maintain peak proficiency for complex multi-organ cases often seen in advanced polycystic kidney disease.
Patient Consensus: Patients emphasize the need to start the Korean Organ Transplantation Registry paperwork early. Those who chose Asan Medical Center specifically praised the experienced surgeons and dedicated support for international patients.
South Korea offers sophisticated non-surgical management for polycystic kidney disease through Tolvaptan medication and clinical research. Major Seoul-based medical centers provide access to phase 4 pharmacological trials and innovative arterial stem cell therapies. Most protocols focus on slowing cyst growth and preserving organ function.
Bookimed Expert Insight: Korea is a leader in digitalized medicine which significantly improves safety during longitudinal PKD care. Seoul National University Bundang Hospital was the first digital hospital globally. Their BESTcare system uses AI to analyze EHRs and track progression. This digital focus helps doctors identify small changes in cyst volume faster than traditional manual reviews.
Patient Consensus: Patients note it's important that international clinics in Seoul provide personalized coordination. Many find that having experts handle translations and appointments makes specialized pharmacological therapy much easier to manage.